Prospective, active, population-based surveillance for suspected meningitis in children aged 2-59 months was conducted (February 2002-January 2011) in 6 hospitals. Clinical data, blood, and cerebrospinal fluid were collected. The impact of Hib conjugate vaccine was assessed by comparing Hib and all cause meningitis data in the 3 years preceding pentavalent conjugate vaccine implementation (2002-2004) with 3 years postimplementation (2008-2010).
Five hundred eleven cases of suspected meningitis were identified from 2002-2011. Pentavalent conjugate vaccine coverage in December 2005 in Ulaanbaatar city was 97 % . The proportion of suspected cases confirmed as Hib meningitis decreased from 25 % (50/201) in the prevaccination era to 2 % (4/193) in the postvaccination era (P?<?.0001). The annual incidence of Hib decreased from 28 cases per 100?000 children in 2002-2005 to 2 per 100?000 in 2008-2010 (P < .0001).
This article demonstrates the marked impact of Hib conjugate vaccine introduction on meningitis?in Mongolia. It is important to sustain this surveillance system to monitor the long-term impact of Hib conjugate vaccine, as well as other interventions such as pneumococcal and meningococcal vaccines.